Department of Biochemistry, Faculty of Medicine, Fukuoka University, Nanakuma, Jonan-ku, Fukuoka, Japan.
Anticancer Res. 2013 Jul;33(7):2823-31.
Photodynamic therapy (PDT) is a well-established clinical treatment modality for various diseases, including cancer. It involves the topical or systemic administration of a photosensitizer, followed by selective irradiation of the target lesion with a specific wavelength of non-ionizing light, which triggers oxidative photodamage and subsequent death of the targeted cells. Due to this two-step therapeutic process, PDT is a safe and minimally-invasive therapy. Nevertheless, classical non-targeted photosensitizers lack sufficient tumor selectivity and are taken up in the neighboring normal tissues, resulting in undesirable adverse effects. To overcome this obstacle, diverse tumor-targeting approaches have been developed. In this article, we discuss the current strategies and rationale regarding tumor-targeted PDT.
光动力疗法(PDT)是一种成熟的临床治疗方法,可用于多种疾病的治疗,包括癌症。它涉及光敏剂的局部或全身给药,然后用特定波长的非电离光选择性地照射靶病变,从而引发氧化光损伤和随后靶向细胞的死亡。由于这种两步治疗过程,PDT 是一种安全且微创的治疗方法。然而,经典的非靶向光敏剂缺乏足够的肿瘤选择性,并且被摄取到相邻的正常组织中,导致不良的不良反应。为了克服这一障碍,已经开发了多种肿瘤靶向方法。在本文中,我们讨论了肿瘤靶向 PDT 的当前策略和原理。